Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers
Medicine
[키워드] Admission
antibody
antibody kinetics
Antibody Response
Asymptomatic
Asymptomatic carrier
Asymptomatic case
Asymptomatic COVID-19
average
C-reactive protein
carrier
changes in
children
clearance of SARS-CoV-2
Clinical characteristics
contribute
COVID-19
COVID-19 patient
enrolled
follow-up period
IgA
IgG
IgG and IgM
IgM
information
initial
interleukin-6
Kinetics
nasopharyngeal
Patient
patients
peaked
positive
pre-symptomatic
quantitative PCR
remained
RNA
SARS-CoV-2
seropositive
Spread
Symptom
symptomatic patient
Symptomatic patients
tested
the SARS-CoV-2
three groups
threshold
total antibody
transcriptase
viral clearance
viral kinetics
viral nucleic acid
was tested
without symptom
[DOI] 10.3389/fmed.2021.595773 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.595773 PMC 바로가기 [Article Type] Medicine